Frontlight ResearchEarly access
Taking people in United StatesNo phase
EEG Abnormalities in Adult ICU Patients With High Risk of Delirium
Key facts
- Who runs it
- Ceribell Inc.
- Where
- Nashville, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 16 Apr 2026
- Expected to end
- 30 Sept 2027
- Type of study
- Observational
- Treatments tested
- Ceribell EEG System
- Record updated
- 21 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Adult patient ≥18 years old
- Requiring admission to a medical, surgical and/or cardiovascular ICU for an expected duration ≥ 24 hours
- Receiving treatment for shock (e.g., with vasopressors, intra-aortic balloon pump, or Extracorporeal Membrane Oxygenation therapy) and/or respiratory failure [e.g., on mechanical ventilation or non-invasive positive pressure ventilation (NIPPV)]
Who cannot take part
- Patients who have been on mechanical ventilation for >72 hours within the current hospitalization or who are on long-term ventilator support prior to the injury that resulted in the current hospitalization
- Any structural abnormality or head condition, including the presence of a device, that would prevent the use of the Ceribell EEG system for the entire anticipated EEG monitoring period. Examples include: Craniectomy with a missing bone flap in a region where Ceribell EEG electrodes would be placed
- Anticipated use of continuous EEG for a purpose other than delirium detection during the entire expected monitoring period
- Expected death within 12 hours of enrollment or lack of commitment to treatment by family or the medical team (e.g., likely to withdraw life support measures within 12 hours of enrollment)
- Acute or chronic neurologic deficit precluding CAM-ICU assessments
- Inability to understand English
- Bilateral Deafness
- Blindness that will preclude delirium evaluation
- Current enrollment in a study that does not allow co-enrollment
- Inability to obtain informed consent
- Attending physician refusal
- Patient and/or surrogate refusal
- Patient unable to consent and no surrogate available
- Prisoners
Where in United States
- Vanderbilt University Medical CenterNashville, United StatesContact: Anya HardenTaking people
About the trial
What the trial wants to find out
The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium
The group in the trial
- Prospective Ceribell Delirium Monitoring
Enrolled patients will undergo EEG monitoring with the Ceribell EEG System twice daily for up to 7 days.
Treatment: Ceribell EEG System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 21 April 2026